Skip to main content
Corrigendum to: Microfluidic enrichment of plasma cells improves treatment of multiple myeloma
Abstract
The following statement has been added to the subsection 2.1 of Materials and methods of the paper by Zeng et al.1: ‘The study is approved by the Chinese Ethics Committee of Registering Clinical Trials (ID: ChiECRCT-20160046) and conformed to the standards set by the Declaration of Helsinki’.
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.